12.01.2022 • NewsOquema

Oqema Buys Spain’s Tecnufar Iberia

German chemical distributor Oqema has bought Spain’s Tecnufar Iberia, strengthening its presence in the region’s food ingredients and additives market. Tecnufar, which has about 20 employees, is headquartered in Madrid, where it also operates a warehouse along with two others in Barcelona and Valencia.

"Our roots are medium-sized and family-run. Oqema is therefore the best possible partner for us to marry our local roots and spirit with the benefits of an international distribution company,” said Andres Herepey, managing director of Tecnufar Iberia. Herepey will continue his role with the company post Oqema’s acquisition.

Oqema said it will continue to recognize and seize growth opportunities to expand its presence in Europe. Last year, the Liedberg-headquartered group made four acquisitions. In January, it took over Germany’s Claus Nitsche & Sohn and bought a majority share in Austria’s CB Chemie, and in April purchased Spain’s Proquibasa. In August, Oqema acquired Casoria, an Irish chemicals and metals distributor.

Author: Elaine Burridge, Freelance Journalist

From left to right: Matthias Mirbach, HUB Director for Southern Europe, Andres...
From left to right: Matthias Mirbach, HUB Director for Southern Europe, Andres Herepey, Managing Director of Tecnufar, María Luisa Carcía López, his wife and Peter Overlack, Managing Director of the OQEMA Group. (c) Oquema Group

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read